Hereditary alpha-tryptasemia in patients with postural orthostatic tachycardia syndrome

J Allergy Clin Immunol Pract. 2024 Feb;12(2):528-529.e1. doi: 10.1016/j.jaip.2023.10.043. Epub 2023 Oct 31.

Authors

Jenny Huang¹, Kamran Imam¹, Jose R Criado², Kathleen T Luskin¹, Yihui Liu³, Leah H Puglisi⁴, Jonathan J Lyons³, Andrew A White⁵

Affiliations

¹ Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, Calif.
² Division of Neurology, Scripps Clinic, San Diego, Calif.
³ Translational Allergic Immunopathology Unit, Laboratory of Allergic Diseases, NIAID, NIH, Bethesda, Md.
⁴ Scripps Department of Research & Development, Scripps Health, San Diego, Calif.
⁵ Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, Calif. Electronic address: [email protected].

PMID: 37918652
PMCID: PMC10922344 (available on 2025-02-01)
DOI: 10.1016/j.jaip.2023.10.043

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Humans
Mast Cell Activation Syndrome*
Patients
Postural Orthostatic Tachycardia Syndrome* / epidemiology
Postural Orthostatic Tachycardia Syndrome* / genetics

Supplementary concepts

Hereditary alpha-tryptasemia syndrome

Grants and funding

UL1 TR002550/TR/NCATS NIH HHS/United States